The Emergence of Genome-Based Drug Repositioning
- 17 August 2011
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (96) , 96ps35
Abstract
Genome-wide methods of mRNA signature analyses permit the high-throughput evaluation of medications for drug repurposing.Keywords
This publication has 23 references indexed in Scilit:
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel DiseaseScience Translational Medicine, 2011
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression DataScience Translational Medicine, 2011
- PREDICT: a method for inferring novel drug indications with application to personalized medicineMolecular Systems Biology, 2011
- Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerJNCI: Journal of the National Cancer Institute, 2010
- Generating Genome-Scale Candidate Gene Lists for PharmacogenomicsClinical Pharmacology & Therapeutics, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- Network pharmacologyNature Biotechnology, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003